Wacker Chemie AG (ETR:WCH)
Germany
· Delayed Price · Currency is EUR | Market Cap | 4.75B |
| Revenue (ttm) | 5.49B |
| Net Income (ttm) | -821.10M |
| Shares Out | 49.68M |
| EPS (ttm) | -16.53 |
| PE Ratio | n/a |
| Forward PE | 284.83 |
| Dividend | 2.50 (2.61%) |
| Ex-Dividend Date | May 8, 2025 |
| Volume | 118,237 |
| Average Volume | 124,074 |
| Open | 96.75 |
| Previous Close | 96.35 |
| Day's Range | 94.60 - 97.20 |
| 52-Week Range | 58.85 - 99.80 |
| Beta | 0.68 |
| RSI | 64.39 |
| Earnings Date | Apr 29, 2026 |
About Wacker Chemie AG
Wacker Chemie AG, together with its subsidiaries, produces and sells chemical products in Europe, Asia, the Americas, and internationally. The company operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. It offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica; and binders and polymeric additives, including dispersible polymer powders and dispersions. The company also provides pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl ... [Read more]
Financial Performance
Financial StatementsNews
Wacker Chemie AG Earnings Call Transcript: Q4 2025
Sales and EBITDA met revised guidance but were impacted by EUR 705 million in restructuring and impairments, resulting in a net loss and no dividend. The PACE program targets EUR 300 million in annual savings, with 1,500 job cuts, while 2026 guidance anticipates modest growth and improved cash flow.
Wacker Chemie Becomes Latest German Company to Cut Jobs in Ailing Labor Market
The company plans to cut more than 1,500 jobs in a move to reduce costs and boost its edge against Chinese competition.
Wacker Chemie to cut over 1,500 jobs by 2027
German chemical company Wacker Chemie said on Thursday it would cut more than 1,500 jobs by 2027 under a cost savings programme it announced last month.
Wacker Chemie AG Earnings Call Transcript: Q3 2025
Q3 2025 saw sales and EBITDA decline amid weak demand, price pressure, and regulatory uncertainty, with all segments affected. Full-year guidance was lowered, and a comprehensive cost-saving program is underway to restore competitiveness and profitability.
Wacker Chemie AG Earnings Call Transcript: Q2 2025
Q2 2025 saw weak demand, intense competition, and currency headwinds, leading to a lowered full-year outlook. Sales and EBITDA declined year-over-year, with segment performance mixed and cost, cash, and growth initiatives prioritized. Net debt rose, and market conditions remain challenging.
Wacker Chemie AG Earnings Call Transcript: Q1 2025
Q1 2025 saw sales of €1.48 billion, down 1% year-over-year, with EBITDA at €127 million due to weak solar and construction demand. Specialty silicones and biopharma showed strength, while trade and tariff uncertainties continue to weigh on the outlook.
Wacker Chemie AG Earnings Call Transcript: Q4 2024
2024 saw lower group sales and EBITDA due to polysilicon weakness, but specialty silicones and biosolutions delivered strong growth. 2025 guidance anticipates higher sales and EBITDA, with continued focus on specialty growth, efficiency, and sustainability.
Wacker Chemie AG Earnings Call Transcript: Q3 2024
Q3 2024 sales fell 6% year-over-year to €1.4 billion, but specialty chemicals and biosolutions delivered strong growth and improved margins. Polysilicon sales declined due to solar market uncertainty, while full-year EBITDA is expected in the upper half of €600–800 million.
Wacker Chemie AG Earnings Call Transcript: Q2 2024
Q2 2024 saw strong Chemicals and Polysilicon results, with group sales at EUR 1.5 billion and EBITDA of EUR 160 million. Full-year EBITDA is expected in the upper half of guidance, with H2 performance to improve, especially in Biosolutions and Polysilicon.